• Home
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Related Links
    • FAQ
    • Peer Review Process
    • News
  • Guide for Authors
    • Author Template
  • Submit Manuscript
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter
Egyptian Journal of Chemistry
arrow Articles in Press
arrow Current Issue
Journal Archive
Volume Volume 64 (2021)
Issue Issue 2
Issue Issue 1
Volume Volume 63 (2020)
Volume Volume 62 (2019)
Volume Volume 61 (2018)
Volume Volume 60 (2017)
Volume Volume 59 (2016)
Volume Volume 58 (2015)
Volume Volume 57 (2014)
Volume Volume 56 (2013)
Volume Volume 55 (2012)
Volume Volume 54 (2011)
Volume Volume 53 (2010)
Radhi, A., Zimam, E., Jafer, E. (2021). New Barbiturate Derivatives as potent in vitro α-Glucosidase Inhibitors. Egyptian Journal of Chemistry, 64(1), 117-123. doi: 10.21608/ejchem.2019.16210.1991
Ali Jabbar Radhi; Ezat Hussein Zimam; Emad Abbas Jafer. "New Barbiturate Derivatives as potent in vitro α-Glucosidase Inhibitors". Egyptian Journal of Chemistry, 64, 1, 2021, 117-123. doi: 10.21608/ejchem.2019.16210.1991
Radhi, A., Zimam, E., Jafer, E. (2021). 'New Barbiturate Derivatives as potent in vitro α-Glucosidase Inhibitors', Egyptian Journal of Chemistry, 64(1), pp. 117-123. doi: 10.21608/ejchem.2019.16210.1991
Radhi, A., Zimam, E., Jafer, E. New Barbiturate Derivatives as potent in vitro α-Glucosidase Inhibitors. Egyptian Journal of Chemistry, 2021; 64(1): 117-123. doi: 10.21608/ejchem.2019.16210.1991

New Barbiturate Derivatives as potent in vitro α-Glucosidase Inhibitors

Article 12, Volume 64, Issue 1, January 2021, Page 117-123  XML PDF (633.94 K)
Document Type: Original Article
DOI: 10.21608/ejchem.2019.16210.1991
Authors
Ali Jabbar Radhi email 1; Ezat Hussein Zimam2; Emad Abbas Jafer3
1Faculty of Pharmacy, Al-Kafeel University, Najaf, Iraq.
2Department of Chemistry, Faculty of Science , Kufa University, Najaf, Iraq
3Babylon Technical Institute, Al-Furat Al-Awsat Technical University, Al-Kuf, Iraq
Receive Date: 25 August 2019,  Revise Date: 30 October 2019,  Accept Date: 26 July 2020 
Abstract
Abstract: A series of new Schiff base derivatives were synthesized by reaction barbiturate derivatives (barbital and phenobarbital) with some aromatic aldehydes. Barbital and phenobarbital were treated with formaldehyde in ethanol as solvent to produce a and b. Then reaction compounds a or b with paratoluenesulfonylchloride in DCM and presence triethylamine to form (1,3(2H,4H)-diyl)bis(methylene)bis(4-methylbenzene sulfonate) barbiturate 1a and 1b. Nucleophilic substitution reaction of compound 1a or 1b with sodium amide or with hydrazine hydrate to form barbiturate derivatives contain free amino group2a, 3a,2b and 3b. barbiturate derivatives which contain free amino or hydraznyl group reacted with some aromatic benzaldehyde to preparation final products 1-8 (Schiff base derivatives). The structures of the prepared derivatives were identified by many spectroscopic methods such as Mass, NMR, FTIR spectroscopy and the elemental analysis(C,H,N). The end products were evaluated in vitro α-glucosidase inhibitory activity. All Schiff base derivatives were showed α-glucosidase inhibition with IC50 values 110 ± 2.15, 197 ± 3.11, 38 ± 0.84, 64 ± 1.78, 119 ± 3.55, 204 ± 2.08, 32 ± 1.42, 81 ± 2.23 µM respectively, when compared to the standard drug acarbose (IC50 =787.27 ± 2.23 µM).
Keywords
Keywords: α-Glucosidase inhibitors; Schiff base; Barbital; Phenobarbital; Diabetes; Acarbose
Main Subjects
Pharmaceutical Chemistry
Statistics
Article View: 101
PDF Download: 32
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Journal Management System. Designed by NotionWave.